These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7798264)

  • 1. Evidence for a second receptor binding site on human prolactin.
    Goffin V; Struman I; Mainfroid V; Kinet S; Martial JA
    J Biol Chem; 1994 Dec; 269(51):32598-606. PubMed ID: 7798264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lactogen receptor-binding site 1 of human prolactin.
    Kinet S; Goffin V; Mainfroid V; Martial JA
    J Biol Chem; 1996 Jun; 271(24):14353-60. PubMed ID: 8662911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based design of prolactin receptor antagonists.
    Fuh G; Colosi P; Wood WI; Wells JA
    J Biol Chem; 1993 Mar; 268(8):5376-81. PubMed ID: 8449901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites.
    Kinet S; Bernichtein S; Kelly PA; Martial JA; Goffin V
    J Biol Chem; 1999 Sep; 274(37):26033-43. PubMed ID: 10473550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a model to understand prolactin and growth hormone specificities.
    Goffin V; Martial JA; Summers NL
    Protein Eng; 1995 Dec; 8(12):1215-31. PubMed ID: 8869634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity.
    Goffin V; Norman M; Martial JA
    Mol Endocrinol; 1992 Sep; 6(9):1381-92. PubMed ID: 1435787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay.
    Goffin V; Kinet S; Ferrag F; Binart N; Martial JA; Kelly PA
    J Biol Chem; 1996 Jul; 271(28):16573-9. PubMed ID: 8663214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids in highly conserved regions near the C-terminus of rat prolactin (PRL) play critical roles similar to those in binding of human GH to the PRL receptor.
    Kato Y; Maruyama O; Chung HO; Tomizawa K; Kato T
    Biochem Biophys Res Commun; 1996 May; 222(2):547-52. PubMed ID: 8670242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.
    Fuh G; Wells JA
    J Biol Chem; 1995 Jun; 270(22):13133-7. PubMed ID: 7768908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
    Peterson FC; Brooks CL
    Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
    Langenheim JF; Tan D; Walker AM; Chen WY
    Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering human prolactin to bind to the human growth hormone receptor.
    Cunningham BC; Henner DJ; Wells JA
    Science; 1990 Mar; 247(4949 Pt 1):1461-5. PubMed ID: 2321008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.
    Jomain JB; Tallet E; Broutin I; Hoos S; van Agthoven J; Ducruix A; Kelly PA; Kragelund BB; England P; Goffin V
    J Biol Chem; 2007 Nov; 282(45):33118-31. PubMed ID: 17785459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay.
    Haro LS; Lee DW; Singh RN; Bee G; Markoff E; Lewis UJ
    J Clin Endocrinol Metab; 1990 Aug; 71(2):379-83. PubMed ID: 2380335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for growth hormone-receptor interactions.
    Wells JA; Cunningham BC; Fuh G; Lowman HB; Bass SH; Mulkerrin MG; Ultsch M; deVos AM
    Recent Prog Horm Res; 1993; 48():253-75. PubMed ID: 8441850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc mediation of the binding of human growth hormone to the human prolactin receptor.
    Cunningham BC; Bass S; Fuh G; Wells JA
    Science; 1990 Dec; 250(4988):1709-12. PubMed ID: 2270485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for ordered receptor binding by human prolactin.
    Sivaprasad U; Canfield JM; Brooks CL
    Biochemistry; 2004 Nov; 43(43):13755-65. PubMed ID: 15504038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling of rabbit prolactin hormone complexed with its receptor.
    Halaby D; Thoreau E; Djiane J; Mornon JP
    Proteins; 1997 Mar; 27(3):459-68. PubMed ID: 9094747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms.
    Pellegrini I; Gunz G; Ronin C; Fenouillet E; Peyrat JP; Delori P; Jaquet P
    Endocrinology; 1988 Jun; 122(6):2667-74. PubMed ID: 3131120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional epitopes for site 1 of human prolactin.
    Rao GV; Brooks CL
    Biochemistry; 2011 Mar; 50(8):1347-58. PubMed ID: 21226500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.